Integumen PLC's (LON:SKIN) Gerry Brandon caught up with Proactive London's Andrew Scott after announcing a collaboration with Avacta PLC (LON:AVCT) to use their technology in a coronavirus (COVID-19) detection kit. He says they've signed a material transfer agreement to use recently-generated affimers that bind the SARS-COV-2 spike protein to pick up the signs of the respiratory infection in wastewater.
Integumen's Gerry Brandon outlines collaboration with Avacta for real-time coronavirus detection
Quick facts: Integumen
Price: 2.812 GBX
Market Cap: £30.33 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Integumen named herein, including the promotion by the Company of Integumen in any Content on the Site, the Company receives from said issuer...FOR OUR FULL DISCLAIMER CLICK HERE